Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xuefeng Yu

Showing results (261-270 of 347) with videos related to

Pageof 35
Sort By:
Journal of Neuroinflammation|August 2, 2024
Inhibition of ANGPTL8 protects against diabetes-associated cognitive dysfunction by reducing synaptic loss via the PirB signaling pathwayXiaoyu Meng, Danpei Li, Ranran Kan, et al.
Biomedicines|May 27, 2026
Efficacy and Safety of Open-Source Hybrid Closed-Loop Automated Insulin Delivery in Perioperative PatientsDelin Ma, Weijie Xu, Yan Yang, et al.
Current Medical Research and Opinion|July 14, 2022
Comparative efficacy and safety of two insulin aspart formulations (Rapilin and NovoRapid) when combined with metformin, for patients with diabetes mellitus: a multicenter, randomized, open-label, controlled clinical trialJun Yao, Xiaohui Guo, Li Sun, et al.
Diabetes, Obesity & Metabolism|December 17, 2023
Efficacy of noiiglutide injection on body weight in obese Chinese adults without diabetes: A multicentre, randomized, double-blind, placebo-controlled, phase 2 trialYijun Li, Zhifeng Cheng, Weiping Lu, et al.
BMJ (Clinical Research Ed.)|January 22, 2025
Dapagliflozin plus calorie restriction for remission of type 2 diabetes: multicentre, double blind, randomised, placebo controlled trialYuejun Liu, Ying Chen, Jianhua Ma, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|November 24, 2025
Gabpα-Pparγ Complex Determines Glycolytic Capacity and Lactic Acid Homeostasis in Brown FatZhihan Wang, Huanyu Wang, Qianqian Kang, et al.
Science Advances|September 28, 2022
Constraining the formation and transport of lunar impact glasses using the ages and chemical compositions of Chang'e-5 glass beadsTao Long, Yuqi Qian, Marc D Norman, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|April 8, 2021
Exenatide Twice Daily Plus Glargine Versus Aspart 70/30 Twice Daily in Patients With Type 2 Diabetes With Inadequate Glycemic Control on Premixed Human Insulin and MetforminXi Chen, Yongping Xu, Jianhua Zhang, et al.
Ebiomedicine|June 6, 2025
AI-based pelvic floor surface electromyography reference ranges and high-precision pelvic floor dysfunction diagnosisJuan Chen, Jiahui Yao, Wei Chen, et al.
Journal of Epidemiology and Community Health|January 8, 2022
Association of education levels with the risk of hypertension and hypertension control: a nationwide cohort study in Chinese adultsKan Sun, Diaozhu Lin, Mian Li, et al.
Pageof 35

Showing results (261-270 of 347) with videos related to

Sort By:
Pageof 35
Journal of Neuroinflammation|August 2, 2024
Inhibition of ANGPTL8 protects against diabetes-associated cognitive dysfunction by reducing synaptic loss via the PirB signaling pathwayXiaoyu Meng, Danpei Li, Ranran Kan, et al.
Biomedicines|May 27, 2026
Efficacy and Safety of Open-Source Hybrid Closed-Loop Automated Insulin Delivery in Perioperative PatientsDelin Ma, Weijie Xu, Yan Yang, et al.
Current Medical Research and Opinion|July 14, 2022
Comparative efficacy and safety of two insulin aspart formulations (Rapilin and NovoRapid) when combined with metformin, for patients with diabetes mellitus: a multicenter, randomized, open-label, controlled clinical trialJun Yao, Xiaohui Guo, Li Sun, et al.
Diabetes, Obesity & Metabolism|December 17, 2023
Efficacy of noiiglutide injection on body weight in obese Chinese adults without diabetes: A multicentre, randomized, double-blind, placebo-controlled, phase 2 trialYijun Li, Zhifeng Cheng, Weiping Lu, et al.
BMJ (Clinical Research Ed.)|January 22, 2025
Dapagliflozin plus calorie restriction for remission of type 2 diabetes: multicentre, double blind, randomised, placebo controlled trialYuejun Liu, Ying Chen, Jianhua Ma, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|November 24, 2025
Gabpα-Pparγ Complex Determines Glycolytic Capacity and Lactic Acid Homeostasis in Brown FatZhihan Wang, Huanyu Wang, Qianqian Kang, et al.
Science Advances|September 28, 2022
Constraining the formation and transport of lunar impact glasses using the ages and chemical compositions of Chang'e-5 glass beadsTao Long, Yuqi Qian, Marc D Norman, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|April 8, 2021
Exenatide Twice Daily Plus Glargine Versus Aspart 70/30 Twice Daily in Patients With Type 2 Diabetes With Inadequate Glycemic Control on Premixed Human Insulin and MetforminXi Chen, Yongping Xu, Jianhua Zhang, et al.
Ebiomedicine|June 6, 2025
AI-based pelvic floor surface electromyography reference ranges and high-precision pelvic floor dysfunction diagnosisJuan Chen, Jiahui Yao, Wei Chen, et al.
Journal of Epidemiology and Community Health|January 8, 2022
Association of education levels with the risk of hypertension and hypertension control: a nationwide cohort study in Chinese adultsKan Sun, Diaozhu Lin, Mian Li, et al.
Pageof 35